Toxic cardiac effects of catecholamines:: role of β-adrenoceptor downregulation

被引:35
作者
Brouri, F
Findji, L
Mediani, O
Mougenot, N
Hanoun, N
Le Naour, G
Hamon, M
Lechat, P
机构
[1] Hop La Pitie Salpetriere, Serv Pharmacol, F-75651 Paris 13, France
[2] Univ Paris 06, INSERM, U288, Paris, France
[3] Univ Paris 06, Dept Pathol, Paris, France
关键词
beta-adrenoceptor; autonomic nervous system; contractility; fibrosis; heart failure;
D O I
10.1016/S0014-2999(02)02643-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of our study was to analyse the mechanisms underlying cardiac toxicity caused by beta-adrenoceptor stimulation and the relationships with their associated downregulation during heart failure. We used the experimental model of coronary artery ligation-induced myocardial infarction in male Wistar rats. In order to increase beta-adrenergic stimulation, rats were subjected to a 15-day chronic isoprenaline administration (30 mug/kg/h). Isoprenaline administration induced haemodynamic inotropic compensation, almost abolished in vitro inotropic response to isoprenaline on papillary muscle (P<0.005) but promoted fibrosis. Isoprenaline treatment markedly reduced the B-max of beta(2)-adrenoceptors (by 53% in sham and 44% in infarcted rats) but not that of beta(1)-adrenoceptors. These results suggest that beta(1)-adrenoceptors rather than beta(2)-adrenoceptors underlie the deleterious effects of chronic beta-adrenergic stimulation on cardiac fibrosis and are in agreement with the demonstrated benefit induced in human heart failure by beta(1)-adrenoceptor antagonists. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 30 条
  • [1] BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cellbio.4.1.405
  • [2] INCREASE OF GI-ALPHA IN HUMAN HEARTS WITH DILATED BUT NOT ISCHEMIC CARDIOMYOPATHY
    BOHM, M
    GIERSCHIK, P
    JAKOBS, KH
    PIESKE, B
    SCHNABEL, P
    UNGERER, M
    ERDMANN, E
    [J]. CIRCULATION, 1990, 82 (04) : 1249 - 1265
  • [3] Catecholamine effects on cardiac remodelling, oxidative stress and fibrosis in experimental heart failure
    Bonnefont-Rousselot, D
    Mahmoudi, A
    Mougenot, N
    Varoquaux, O
    Le Nahour, G
    Fouret, P
    Lechat, P
    [J]. REDOX REPORT, 2002, 7 (03) : 145 - 151
  • [4] BETA-1-ADRENERGIC-RECEPTOR AND BETA-2-ADRENERGIC-RECEPTOR SUBPOPULATIONS IN NONFAILING AND FAILING HUMAN VENTRICULAR MYOCARDIUM - COUPLING OF BOTH RECEPTOR SUBTYPES TO MUSCLE-CONTRACTION AND SELECTIVE BETA-1-RECEPTOR DOWN-REGULATION IN HEART-FAILURE-
    BRISTOW, MR
    GINSBURG, R
    UMANS, V
    FOWLER, M
    MINOBE, W
    RASMUSSEN, R
    ZERA, P
    MENLOVE, R
    SHAH, P
    JAMIESON, S
    STINSON, EB
    [J]. CIRCULATION RESEARCH, 1986, 59 (03) : 297 - 309
  • [5] Myocardial β-adrenergic reactivity in pressure overload-induced cardiac hypertrophy in the rat
    Communal, C
    Ribuot, C
    Durand, A
    Demenge, P
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1998, 12 (06) : 590 - 598
  • [6] INCREASED MESSENGER-RNA LEVEL OF THE INHIBITORY-G PROTEIN ALPHA-SUBUNIT GI-ALPHA-2 IN HUMAN END-STAGE HEART-FAILURE
    ESCHENHAGEN, T
    MENDE, U
    NOSE, M
    SCHMITZ, W
    SCHOLZ, H
    HAVERICH, A
    HIRT, S
    DORING, V
    KALMAR, P
    HOPPNER, W
    SEITZ, HJ
    [J]. CIRCULATION RESEARCH, 1992, 70 (04) : 688 - 696
  • [7] [H-3]Alnespirone: A novel specific radioligand of 5-HT1A receptors in the rat brain
    Fabre, V
    Boni, C
    Mocaer, E
    Lesourd, M
    Hamon, M
    Laporte, AM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 337 (2-3) : 297 - 308
  • [8] INCREASE OF THE 40,000-MOL WT PERTUSSIS TOXIN SUBSTRATE (G-PROTEIN) IN THE FAILING HUMAN-HEART
    FELDMAN, AM
    CATES, AE
    VEAZEY, WB
    HERSHBERGER, RE
    BRISTOW, MR
    BAUGHMAN, KL
    BAUMGARTNER, WA
    VANDOP, C
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (01) : 189 - 197
  • [9] HEART-FAILURE IN THE 1990S - EVOLUTION OF A MAJOR PUBLIC-HEALTH PROBLEM IN CARDIOVASCULAR MEDICINE
    GARG, R
    PACKER, M
    PITT, B
    YUSUF, S
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (04) : A3 - A5
  • [10] The negative inotropic effect of β3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle
    Gauthier, C
    Leblais, V
    Kobzik, L
    Trochu, JN
    Khandoudi, N
    Bril, A
    Balligand, JL
    Le Marec, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) : 1377 - 1384